Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aviragen Therapeutics Inc (NASDAQ:AVIR)

0.828
Delayed Data
As of Oct 23
 +0.0678 / +8.92%
Today’s Change
0.43
Today|||52-Week Range
1.60
-32.68%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close0.76
Today’s open0.78
Day’s range0.78 - 0.84
Volume590,690
Average volume (3 months)386,937
Market cap$29.4M
Dividend yield--
Data as of 10/23/2017

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-4.30%
P/E ratioNM
Price/Sales2.91
Price/Book1.57

Competitors

 Today’s
change
Today’s
% change
SNOASonoma Pharmaceutica...-0.07-1.50%
OCRXOcera Therapeutics I...-0.03-2.75%
CAPRCapricor Therapeutic...-0.02-0.87%
DFFNDiffusion Pharmaceut...-0.04-2.57%
Data as of 10/23/2017

Financials

Last reporting dateAugust 31, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$8.9M
Annual profit (last year)-$29.4M
Net profit margin-330.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts